rp 59227 has been researched along with Heart Disease, Ischemic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auchampach, JA; Cavero, I; Gross, GJ; Pieper, GM | 1 |
1 other study(ies) available for rp 59227 and Heart Disease, Ischemic
Article | Year |
---|---|
Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
Topics: Animals; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Free Radicals; Incidence; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neutrophils; Peroxidase; Platelet Activating Factor; Pyridines; Reperfusion Injury; Thiazoles; Ventricular Fibrillation | 1998 |